Td Asset Management Inc Apellis Pharmaceuticals, Inc. Transaction History
Td Asset Management Inc
- $106 Billion
- Q4 2024
A detailed history of Td Asset Management Inc transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 38,692 shares of APLS stock, worth $704,194. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,692
Previous 238,212
83.76%
Holding current value
$704,194
Previous $6.87 Million
82.04%
% of portfolio
0.0%
Previous 0.01%
Shares
23 transactions
Others Institutions Holding APLS
# of Institutions
299Shares Held
111MCall Options Held
2.63MPut Options Held
845K-
Avoro Capital Advisors LLC New York, NY12.2MShares$222 Million5.68% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$216 Million17.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$183 Million0.01% of portfolio
-
Morgan Stanley New York, NY9.63MShares$175 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$105 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...